IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.

CONCLUSION: The rCBVmax-t or rCBVmax-p may serve as preferable and comparable imaging biomarkers for evaluation of glioblastomas IDH status. The combination of rADCmin-t and rCBVmax-t may yield the maximum predictive power for differentiating IDH status. PMID: 31084193 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31084193?dopt=Abstract

Source: Acta Radiologica - May 12, 2019 Category: Radiology Authors: Xing Z, Zhang H, She D, Lin Y, Zhou X, Zeng Z, Cao D Tags: Acta Radiol Source Type: research

More News: Brain Tumor | Glioma | Radiology